COVID-19 Vaccines
Dosage interval of Covishield vaccine revised to 4 to 8 weeks
1 min read
By Ministry of Health and Family Welfare - 23 March 2021, Updated on - 18 October 2022
Share this article
3
13 likes
COVID-19 Vaccines
Leave Comment
Recommended for you
COVID-19 Vaccines
What Disruptive Technologies Are Being Used for COVID-19 Vaccines?
The pandemic has resulted in an unprecedented loss of life and economic damage. As of now, a safe and effective vaccine appears to be humanity’s only hope against the pandemic.
COVID-19 Vaccines
Who Should and Should Not Take the COVID-19 Vaccine?
Although the percentage of adverse events following immunization is very small, it is important to spread awareness about who should get the COVID-19 vaccine and who should not.
COVID-19 Vaccines
COVID-19 Vaccines: How close are we?
Know the latest happenings in the COVID-19 vaccine landscape. At the moment, 156 vaccines are in pre-clinical evaluation while 42 are in the clinical evaluation stage. One vaccine in India is in the phase III clinical trial.
Subscribe
Sign up for our free Health Library Daily Newsletter
Get doctor-approved health tips, news, and more.
Visual Stories
Getting vaccinated? Know the DOs and DON'Ts
Tap to continue exploring
Recommended for you
COVID-19 Vaccines
What Disruptive Technologies Are Being Used for COVID-19 Vaccines?
The pandemic has resulted in an unprecedented loss of life and economic damage. As of now, a safe and effective vaccine appears to be humanity’s only hope against the pandemic.
COVID-19 Vaccines
Who Should and Should Not Take the COVID-19 Vaccine?
Although the percentage of adverse events following immunization is very small, it is important to spread awareness about who should get the COVID-19 vaccine and who should not.
COVID-19 Vaccines
COVID-19 Vaccines: How close are we?
Know the latest happenings in the COVID-19 vaccine landscape. At the moment, 156 vaccines are in pre-clinical evaluation while 42 are in the clinical evaluation stage. One vaccine in India is in the phase III clinical trial.